Ghanaian President Nana Akufo-Addo has disclosed that the Committee set up to recommend the appropriate decision on the deployment of a safe Covid-19 vaccine in Ghana has concluded its work enabling the government to begin discussions with vaccine manufacturing companies.
The Ghanaian President made the statement in an address at the 72nd Annual New Year School and Conference in the capital Accra.
He said the goal of the discussion was to order the most suitable vaccine for Ghana.
President Akufo-Addo said the goal of the discussion was to order the most suitable vaccine for the country.
“Through the advances of science, we now have vaccines that are already being administered in some countries that could help control and eventually end the pandemic. The Committee formed by government to recommend the appropriate decision on COVID-19 vaccines has completed its work, enabling government to begin discussions with vaccine-manufacturing companies with the goal of ordering the suitable doses of the vaccine for use in Ghana. Details of this will be announced very soon”. He said.
Ghana’s FDA is yet to approve a COVID-19 vaccine for use in the country and last week, the country issued a Public Health Alert against the patronage of any vaccine.
However, some countries in Europe and North America have commenced the use of certain vaccines.
The United States FDA has approved two vaccines; Pfizer vaccine on December 11 and the Moderna vaccine on December 18, 2020. The vaccines are currently being distributed across the US to battle the pandemic.
Three vaccines have been approved in the UK, the Pfizer, Moderna and AstraZeneca vaccines.
The Pfizer, Oxford and Moderna vaccines each require two doses and a person is not fully vaccinated until a week after your second shot is taken.
Meanwhile, some African countries have also commenced their own vaccination process. Late last year, Guinea began vaccinating against COVID-19 with the Russian Sputnik V vaccine on an experimental basis, starting with government officials. The country ordered only 55 doses of the Russian vaccine.